News & Events
Recent News
Upcoming Events
-
Technology Opportunity Webinar: Nestorone®/Testosterone Male Contraceptive Gel
In this free, NIH webinar hosted by TTC, attendees will learn about a first-of-its-kind male contraceptive hormonal gel, Nestorone/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical daily self-applied transdermal gel is designed to provide full sperm suppression within 8-12 weeks and be reversible after 12-16 weeks of ending application. This presentation will showcase NES/T gel as an innovative user-controlled option for male contraception.
December 12, 2023 | 11:00 AM – 12:00 PM